trial · primary record
Survodutide formulation A
Healthy
| Phase | Phase 1 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 44 |
| Primary completion | 2026-12-22 |
| Primary endpoint | Area under the concentration-time curve of the analyte in plasma over the time interval from 0 to the last quantifiable data point (AUC0-tz) |
| Registry ID | NCT07768813 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:41:27.731Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07768813
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.